STOCK TITAN
  1. Home
  2. Sec-filings
  3. HLN
  4. [6-K] Haleon plc Current Report (Foreign Issuer)

Haleon (NYSE: HLN) cancels 6.99M shares after June buyback

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

Haleon plc reports it has purchased 6,992,435 ordinary shares of £0.01 each for cancellation under its share buyback programme announced on 12 March 2026. The purchases were made on 22 and 23 June 2026 across the London Stock Exchange, Cboe UK venues and Aquis at volume weighted average prices around 332–334 pence per share.

After settlement, Haleon’s registered share capital is 8,820,906,422 ordinary shares, including 12,006,714 treasury shares. The number of ordinary shares with voting rights is now 8,808,899,708, which shareholders can use when assessing disclosure thresholds under UK transparency rules.

Positive

  • None.

Negative

  • None.
Shares repurchased for cancellation 6,992,435 shares Under share buyback programme announced 12 March 2026
VWAP 22 June LSE 332.1356 pence/share Volume weighted average price on London Stock Exchange, 22 June 2026
VWAP 23 June LSE 334.4367 pence/share Volume weighted average price on London Stock Exchange, 23 June 2026
Registered share capital 8,820,906,422 shares Ordinary shares of £0.01 each after settlement
Treasury shares 12,006,714 shares Held in treasury after reported buybacks
Shares with voting rights 8,808,899,708 shares Ordinary shares with voting rights after settlement
Highest price paid 335.0000 pence/share Maximum price reported on 23 June 2026
share buyback programme financial
"for cancellation under its share buyback programme announced on 12 March 2026"
A share buyback programme is when a company uses its cash to purchase its own shares from the market, reducing the number of shares available to other investors; imagine a bakery buying back coupons so fewer are circulating. It matters because cutting the share count can boost earnings per share and increase each remaining investor’s ownership stake, and it also signals management’s view of the stock while using cash that could have been spent on other priorities.
treasury shares financial
"of which 12,006,714 are held as treasury shares"
Treasury shares are a company’s own stock that it has repurchased and keeps on its books instead of canceling or leaving in the hands of outside investors. Think of them like coupons a business puts back in a drawer: they don’t vote or receive dividends while held, but they can be reissued later for employee pay or fundraising. For investors this matters because buybacks change the number of shares that count toward earnings and ownership, can boost per‑share metrics, and use corporate cash that might otherwise go to growth or dividends.
volume weighted average price financial
"Volume weighted average price paid per Share (p)"
The volume weighted average price (VWAP) is a way to measure the average price of a security, such as a stock, over a specific period, taking into account how many units were traded at each price. It’s similar to calculating the average cost of items bought when some are more frequently purchased than others. Investors use VWAP to assess whether a security is being bought or sold at a fair price during trading.
ordinary shares financial
"ordinary shares of £0.01 each in the Company"
Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.
Market Abuse Regulation regulatory
"In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as it applies in the UK (the Market Abuse Regulation)"
Market abuse regulation consists of laws and rules designed to prevent dishonest or manipulative practices in financial markets. It aims to ensure fair and transparent trading, so investors can trust that markets operate honestly, much like rules that keep a game fair. By reducing unfair advantages, it helps protect investor confidence and promotes healthy, efficient markets.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 6-K: How Foreign Companies Report to the SEC →

UNITED STATES
 
SECURITIES AND EXCHANGE COMMISSION
 
Washington, D.C. 20549
 
 
FORM 6-K
 
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
 
For the month of June 2026
 
Commission File Number: 001-41411
 
Haleon plc
(Translation of registrant’s name into English)
 
Building 5, First Floor, The Heights,
Weybridge, Surrey, KT13 0NY
(Address of principal executive offices)
 
 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
 
 
Form 20-F ☒
 
Form 40-F ☐
 
 
 
EXHIBIT INDEX
 
Exhibit Number
Description
99.1
29 June 2026 - “Transactions in Own Shares”
 
 
99.1
 
Haleon plc: Aggregated information - transactions in own shares
 
29 June 2026: Haleon plc (the "Company" or "Haleon") today announces the purchase of 6,992,435 ordinary shares of £0.01 each in the Company (the "Shares") for cancellation under its share buyback programme announced on 12 March 2026.
 
 
London Stock Exchange
CBOE (UK)/BXE
CBOE (UK)/CXE
Aquis
Date of purchase:
22 June 2026
Number of Shares purchased:
1,834,353
867,176
895,922
394,984
Highest price paid per Share (p):
333.8000
333.8000
333.8000
333.5000
Lowest price paid per Share (p):
329.5000
329.5000
329.5000
329.5000
Volume weighted average price paid per Share (p):
332.1356
332.1429
332.2807
332.1128
Date of purchase:
23 June 2026
Number of Shares purchased:
1,749,546
754,902
495,552
-
Highest price paid per Share (p):
335.0000
335.0000
335.0000
-
Lowest price paid per Share (p):
333.1000
333.1000
333.1000
-
Volume weighted average price paid per Share (p):
334.4367
334.4425
334.3200
-
Date of purchase:
24 June 2026
Number of Shares purchased:
-
-
-
-
Highest price paid per Share (p):
-
-
-
-
Lowest price paid per Share (p):
-
-
-
-
Volume weighted average price paid per Share (p):
-
-
-
-
Date of purchase:
25 June 2026
Number of Shares purchased:
-
-
-
-
Highest price paid per Share (p):
-
-
-
-
Lowest price paid per Share (p):
-
-
-
-
Volume weighted average price paid per Share (p):
-
-
-
-
Date of purchase:
26 June 2026
Number of Shares purchased:
-
-
-
-
Highest price paid per Share (p):
-
-
-
-
Lowest price paid per Share (p):
-
-
-
-
Volume weighted average price paid per Share (p):
-
-
-
-
 
Following the settlement of the above, the Company's registered share capital is 8,820,906,422 ordinary shares of £0.01 each, of which 12,006,714 are held as treasury shares. Therefore, the number of ordinary shares with voting rights is 8,808,899,708 and this figure may be used by shareholders to determine if they are required to notify their interest, or a change to their interest, in Haleon under the FCA's Disclosure Guidance and Transparency Rules.
 
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as it applies in the UK (the Market Abuse Regulation), a full breakdown of the individual trades is available at the link below:
 
http://www.rns-pdf.londonstockexchange.com/rns/0378K_1-2026-6-26.pdf
 
This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.
 
This announcement and individual trade breakdown will also be available on the Company's website at: www.haleon.com/investors.
 
Enquiries
 
 
Investors
Media
 
Jo Russell  
+44 7787 392441
Zoë Bird
+44 7736 746167
Rakesh Patel     
+44 7552 484646
Victoria Durman
+44 7894 505730
Email: investor-relations@haleon.com
Email: corporate.media@haleon.com
 
About Haleon
Haleon (LSE/NYSE: HLN) is a consumer company that is solely focused on better everyday health. Our people, our brands, our research, our investment and our innovation are aimed at improving the everyday health of consumers. Our product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Our superior brands - such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren - are trusted by more than one billion consumers and are recommended by health professionals around the world.
 
For more information, please visit www.haleon.com. 
 
 
 
 
SIGNATURE
 
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
 
HALEON PLC
(Registrant)
 
Date: June 29, 2026
By:
/s/ Amanda Mellor
 
 
Name:
Amanda Mellor
 
 
Title:
Company Secretary

Source: View Original Filing on SEC EDGAR